Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore. Excepteur sint lorem cupidatat.

You may like:

New Views: Patient-Centered Treatment of Psoriasis and Psoriatic Arthritis

New Views: Patient-Centered Treatment of Psoriasis and Psoriatic Arthritis

Leading dermatology/rheumatology faculty and a patient presenter explored changes in the psoriasis/psoriatic arthritis landscape via an interactive program featuring TED Talk-style presentations, patient storytelling, and a faculty panel discussion. They focused on advances in the clinical areas of psoriasis and psoriatic arthritis, as well as how these advances introduce changes in the lives of people suffering from psoriatic disease, the increased complexity of care, and changes in routine clinical practice due to new, increasingly efficacious treatments. The workshop concluded with key teaching points and a Q&A session.

  • April Armstrong, MD, MPH
    Associate Dean for Clinical Research,
    Associate Professor of Dermatology,
    Director of Clinical Research, Clinical and Translational Science Institute
    Director of Clinical Trials and Outcomes Research,
    Director of Psoriasis Program,
    Department of Dermatology
    Keck School of Medicine of USC
    Los Angeles, California

  • Rebecca Muntean, MD, ND, FACR
    Clinical Rheumatologist,
    Providence Health & Services
    University of Washington WWAMI Regional Medical Education
    Providence Spokane Internal Medicine
    Premier Clinical Research
    Spokane, Washington

  • Melodie Young, MSN, ANP-C
    Nurse Practitioner,
    Modern Dermatology
    Modern Research Associates
    Dallas, Texas

Disclosure and Conflict of Interest Resolution

Educational activities provided by Forefront Collaborative and The Interstate Postgraduate Medical Association must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below as they were at the time of this activity.

*The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.

The following individuals have indicated that neither they nor their spouses/partners have had, in the past 12 months, financial relationship(s) with commercial interests relative to the content of this CME activity:

  • Planners (Forefront Collaborative): Miranda Armie and Marianna Shershneva, MD, PhD
  • Planner: Fred Martin, MD
  • Planner: Dan Sommer
  • Presenter: Lisa Lambert

The following individuals have disclosed that they and/or their spouse/partner have had a financial relationship in the past 12 months:

  • Planner: Lakshi Aldredge, MSN, ANP-BC: consultant and speaker for AbbVie, Celgene, and Lilly; consultant for Novartis
  • Planner (Forefront Collaborative): Lilia Zurkovsky, PhD had received salary and stock ownership from Teva Pharmaceuticals
  • Presenter: April Armstrong, MD, MPH: consultant for Novartis, Sanofi, Regeneron, Pfizer, Celgene, Modernizing Medicine, AbbVie, Lilly, Merck, and Janssen; speaker and researcher for Lilly, AbbVie, and Janssen
  • Presenter: Rebecca Muntean MD, ND, FACR: speaker for Janssen
  • Presenter: Melodie Young MSN, ANP-C: advisor for AbbVie, Janssen, Lilly, and Novartis, speaker for AbbVie, Janssen, Lilly, and Novartis, and consultant for AbbVie


As a result of participation in this educational activity, participants should increase their ability to:

  • Discuss

    Discuss new and emerging treatments for psoriasis and psoriatic arthritis

  • Screen patients with psoriasis for psoriatic arthritis at each visit

  • Reflect on recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) for treatment of psoriatic arthritis

  • Utilize practical treatment considerations for patients with challenging comorbidities

  • Coordinate care with rheumatology providers and other healthcare providers who treat patients with psoriasis and psoriatic arthritis


There are no resources listed for this course at this time.

Activity Information

Target Audience
The target audience for this educational activity was nurse practitioners and physician assistants who specialize in dermatology. Dermatologists and other clinicians who are members of the healthcare team providing care for patients with psoriasis also may have benefited from participation in this educational activity.

Accreditation Statement
Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Forefront Collaborative designated this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Interstate Postgraduate Medical Association is approved by the California Board of Registered Nursing, Provider Number 6971, for 1.5 contact hours. Each person should retain this certificate for 4 years after the course has been completed. RNs outside of California must verify with their licensing agency for approval of this course.

This activity was approved for 1.25 contact hour(s) of continuing education (which includes up to 0.25 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 17052691.  This activity was planned in accordance with AANP CE Standards and Policies.

CME Content Review
The content of this activity was independently peer reviewed. The reviewers of this activity have no relevant financial relationships to disclose.

This continuing medical education activity may have included reference(s) to unlabeled or unapproved uses of drugs or devices.

The views and opinions expressed in this activity are those of the faculty and did not necessarily reflect the views or recommendations of Forefront Collaborative, Interstate Postgraduate Medical Association, and Lilly.

This activity is provided by Forefront Collaborative in collaboration with Interstate Postgraduate Medical Association.

Commercial Support
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.